October 27, 2025

How Hormones May Influence Tirzepatide Outcomes

Researchers show how reproductive stage and hormone therapy influence weight-loss outcomes in women treated with tirzepatide.

Conexiant

October 23, 2025

Chest Pain & Shock After a Tuna Sandwich: What’s Your Diagnosis?

A 30-year-old man with no prior medical history developed cardiogenic shock shortly after eating a tuna sandwich. He experienced central, burning chest pain, diaphoresis, and generalized pruritus. His pain worsened with breathing and did not respond to nitroglycerin.

Conexiant

October 09, 2025

Is Postoperative AF Changing Anticoagulation Decisions?

Cohort of 198 coronary artery bypass grafting patients monitored for 1 year with insertable cardiac devices found high incidence of new-onset atrial fibrillation but minimal late burden.

Conexiant

September 19, 2025

Join Mount Sinai at TCT® 2025! October 25-28, 2025

October 25-28, 2025 Moscone Center San Francisco, CA

Mount Sinai New York

September 07, 2025

Speckle Tracking Detects Early Diastolic Dysfunction in T2D

In a cross-sectional study presented at ASE 2025, two-dimensional speckle tracking echocardiography identified diastolic abnormalities missed by traditional imaging in over 60% of patients with type 2 diabetes.

Conexiant

November 14, 2024

AI-Powered Camera Detects Hypertension, Diabetes

An AI-powered high-speed video camera offers quick, no-contact screenings for high blood pressure and diabetes by analyzing blood flow features in face and palm skin, achieving impressive accuracies.

Reuters

November 19, 2024

Wide Variation in SGLT2i Use Across U.S. Hospitals

Study reveals hospital variation in SGLT2i prescriptions, with only 11 of 518 hospitals (2.1%) achieving ≥50% prescription rates while 232 hospitals (44.8%) prescribed to fewer than 10% of eligible heart failure patients, highlighting an implementation gap in evidence-based therapy.

Conexiant

December 02, 2024

Can Hidden Fat Predict Alzheimer's Risk?

A study presented at RSNA 2024 demonstrated findings at midlife, decades prior to patients exhibiting early symptoms of Alzheimer's disease related dementia.

Conexiant

May 15, 2024

ACC 2024: Can an App Improve Access to Nonprescription Statins?

A novel web-based application designed to qualify patients with high low-density lipoprotein (LDL) cholesterol for treatment with nonprescription statins may be comparable to physician assessment.

Conexiant